Author

Dongping Wan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Safety of ozanimod and etrasimod in ulcerative colitis

Ozanimod and etrasimod are sphingosine-1-phosphate receptor modulators approved for ulcerative colitis treatment. Given their limited real-world safety data in this specific population, we conducted a disproportionality analysis using the Food and Drug Administration Adverse Event (AE) Reporting System database, aiming...

Long Chen, Dong-Ping Wan, Ben-Kai Xing et al. · Medicine · 0 citations

Review Open access Aug 2026

Preclinical pharmacological effects of epimedium-derived interventions in osteoarthritis: a systematic review and meta-analysis

Botanical metabolites derived from the genus Epimedium demonstrate pharmacological potential in Murine models of OA and likely involve attenuating the production of systemic and local inflammatory factors and ameliorating cartilage damage.

Xiangfei Ji, Rui Tang, Dongping Wan et al. · Frontiers in Pharmacology · 0 citations